1,4-Butanesultam → HCID 71252475, compound
Reaction equation
[S:1]1(=[O:8])(=[O:7])[CH2:6][CH2:5][CH2:4][CH2:3][NH:2]1.Br[C:10]1[CH:11]=[CH:12][C:13]([C:16]([N:18]2[CH2:23][CH2:22][N:21]([C:24]3[C:29]([CH3:30])=[CH:28][C:27]([CH3:31])=[CH:26][N:25]=3)[CH2:20][CH2:19]2)=[O:17])=[N:14][CH:15]=1>>[CH3:30][C:29]1[C:24]([N:21]2[CH2:22][CH2:23][N:18]([C:16]([C:13]3[CH:12]=[CH:11][C:10]([N:2]4[CH2:3][CH2:4][CH2:5][CH2:6][S:1]4(=[O:8])=[O:7])=[CH:15][N:14]=3)=[O:17])[CH2:19][CH2:20]2)=[N:25][CH:26]=[C:27]([CH3:31])[CH:28]=1Participants
3
Procedure
Using [1,2]thiazinane 1,1-dioxide (94 mg) and (5-bromopyridin-2-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (260 mg) described in Preparation Example 134 and by the reaction and treatment in the same manner as in Example 1, the title compound (214 mg) was obtained.
Workup
- customdescribed in Preparation Example 134 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-c36f50d357a541e8a119b46b9cfb7dd1
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…